Showing results 1 to 3 of 3
| Title | Author(s) | Issue Date | Views | |
|---|---|---|---|---|
Biomarker analyses of Asian women with hormone receptor-positive (HR+), HER2-negative (HER2–) advanced breast cancer (ABC) receiving ribociclib (RIB) + endocrine therapy (ET) Proceeding/Conference:ESMO (European Society for Medical On) ASIA 2018 | 2018 | 1 | ||
Calibration method for ESR signal intensity of calcitic shells Journal:Applied Magnetic Resonance | 2000 | 49 | ||
Neratinib in the extended adjuvant treatment of patients from Asia with early-stage HER2+ breast cancer after trastuzumab-based therapy: exploratory analyses from the phase III ExteNET trial Proceeding/Conference:San Antonio Breast Cancer Congress (SABCS) | 2017 | 6 |